The Alzheimer’s Disease Data Initiative (ADDI) aims to move Alzheimer’s disease (AD) innovation further and faster by connecting researchers with the data they need to generate insights to inform development of new, better treatments and diagnostic tools for AD and related dementias.

Our Partners

The partners in ADDI are working together to build better tools for researchers around the world to access, use, and share dementia-related data so that we can accelerate the development of new and more effective treatments for AD.

Today, nearly 50 million people worldwide have Alzheimer’s disease (AD) or related dementias. Researchers estimate that it costs more than $800 billion per year to treat all these patients. And as the world’s elderly population grows, the number of dementia patients worldwide will increase, too—as will the disease’s financial cost—yet we still have no therapies that can slow or reverse its course.

These costs are already squeezing healthcare budgets in developed countries—and if they aren’t addressed, the burden they place on health systems around the world will be debilitating. That’s why, in 2018, Bill Gates and a coalition of partners decided to work together to improve the Alzheimer’s disease and related dementias data ecosystem.

Gates  Notes
Posted November 17, 2020
Quote Mark

I’m optimistic that this will make a real difference in Alzheimer’s research, because there are many examples where we’ve made progress on diseases after bringing together large amounts of data.